OLDWICK, N.J., July 30, 2020 /PRNewswire/ -- Provention
Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical
company dedicated to intercepting and preventing immune-mediated
disease, today announced that it will report its second quarter
2020 financial results on Thursday, August 6, 2020.
In connection with the earnings release, Provention's management
team will host a live conference call and webcast at 8:00 AM ET on Thursday, August 6, 2020, to
discuss the Company's financial results and provide a business
update.
Conference Call Information
To access the call,
please dial 1-888-567-1603 (domestic) or 1-862-298-0702
(international) five minutes prior to the start time and ask to be
connected to the "Provention Bio Call." An audio webcast will also
be available on the "Events and Webcasts" page of the Investors
section of the Company's website, www.proventionbio.com. An
archived webcast will be available on the Company's website
approximately two hours after the conference call and will be
available for seven days following the call.
About Provention Bio, Inc.
Provention Bio, Inc.
(Nasdaq: PRVB) is a biopharmaceutical company leveraging a
transformational drug development strategy focused on the
prevention or interception of immune-mediated disease. Provention's
mission is to source, transform and develop therapeutic candidates
targeting the high morbidity, mortality and escalating costs of
autoimmune diseases. Provention's diversified portfolio includes
teplizumab, a pre-commercial-stage candidate that has been shown to
delay the onset of insulin-dependent type 1 diabetes (T1D) in
at-risk patients during the presymptomatic phase of the disease.
The Company's portfolio includes additional clinical product
development candidates that have demonstrated proof-of-mechanism
and/or proof-of-concept in other autoimmune diseases, including
celiac disease and lupus.
Investors:
Sam Martin,
Argot Partners
sam@argotpartners.com
212-600-1902
Media:
Lori Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:http://www.prnewswire.com/news-releases/provention-bio-to-report-second-quarter-2020-financial-results-and-host-conference-call-on-thursday-august-6-2020-301102826.html
SOURCE Provention Bio, Inc.